GAL3ST3
Galactose-3-O-sulfotransferase 3
Also known as: G3ST3_HUMAN, GAL3ST2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96A11
- Gene
- GAL3ST3
- Ensembl
- ENSG00000175229
- Chromosome
- 11
- Canonical length
- 431 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the galactose-3-O-sulfotransferase protein family. The product of this gene catalyzes sulfonation by transferring a sulfate group to the 3' position of galactose in N-acetyllactosamine in both type 2 (Gal-beta-1-4GlcNAc-R) oligosaccharides and core-2-branched O-glycans, but not on type 1 or core-1-branched structures. This gene, which has also been referred to as GAL3ST2, is different from the GAL3ST2 gene located on chromosome 2 that encodes a related enzyme with distinct tissue distribution and substrate specificities, compared to galactose-3-O-sulfotransferase 3. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
431 residues, UniProt reviewed canonical sequence.
>Q96A11|GAL3ST3
1 MPPILQRLQQ ATKMMSRRKI LLLVLGCSTV SLLIHQGAQL SWYPKLFPLS CPPLRNSPPR
61 PKHMTVAFLK THKTAGTTVQ NILFRFAERH NLTVALPHPS CEHQFCYPRN FSAHFVHPAT
121 RPPHVLASHL RFDRAELERL MPPSTVYVTI LREPAAMFES LFSYYNQYCP AFRRVPNASL
181 EAFLRAPEAY YRAGEHFAMF AHNTLAYDLG GDNERSPRDD AAYLAGLIRQ VEEVFSLVMI
241 AEYFDESLVL LRRLLAWDLD DVLYAKLNAR AASSRLAAIP AALARAARTW NALDAGLYDH
301 FNATFWRHVA RAGRACVERE ARELREARQR LLRRCFGDEP LLRPAAQIRT KQLQPWQPSR
361 KVDIMGYDLP GGGAGPATEA CLKLAMPEVQ YSNYLLRKQK RRGGARARPE PVLDNPPPRP
421 IRVLPRGPQG PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GAL3ST3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 12 nTPM
- basal ganglia: 9.1 nTPM
- cerebellum: 6.8 nTPM
- cerebral cortex: 6 nTPM
- hippocampal formation: 5.6 nTPM
- amygdala: 5.3 nTPM
Single-cell type
- rod photoreceptor cells: 15 nCPM
- oligodendrocyte progenitor cells: 8 nCPM
- brain inhibitory neurons: 7 nCPM
- pituitary stem cells: 6.8 nCPM
- epididymal efferent duct absorptive cells: 6.3 nCPM
- other brain neurons: 5.2 nCPM
Immune cell
- naive CD8 T-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 20 nTPM
- cerebral cortex: 15 nTPM
- cerebellum: 14 nTPM
- hippocampal formation: 13 nTPM
- amygdala: 11 nTPM
- white matter: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.77
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glycolipid biosynthetic process
- oligosaccharide metabolic process
- proteoglycan biosynthetic process
- sulfur compound metabolic process
- monosaccharide metabolic process
- poly-N-acetyllactosamine metabolic process
Molecular functions
- 3'-phosphoadenosine 5'-phosphosulfate binding
- carbohydrate binding
- galactose 3-O-sulfotransferase activity
- galactosylceramide sulfotransferase activity
- proteoglycan sulfotransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GAL3ST3 as an antibody target. Whether an autoantibody or antibody against GAL3ST3 could matter depends on whether native GAL3ST3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GAL3ST3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GAL3ST3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...